» Articles » PMID: 34503684

Medial Arterial Calcification: JACC State-of-the-Art Review

Abstract

Medial arterial calcification (MAC) is a chronic systemic vascular disorder distinct from atherosclerosis that is frequently but not always associated with diabetes mellitus, chronic kidney disease, and aging. MAC is also a part of more complex phenotypes in numerous less common diseases. The hallmarks of MAC include disseminated and progressive precipitation of calcium phosphate within the medial layer, a prolonged and clinically silent course, and compromise of hemodynamics associated with chronic limb-threatening ischemia. MAC increases the risk of complications during vascular interventions and mitigates their outcomes. With the exception of rare monogenetic defects affecting adenosine triphosphate metabolism, MAC pathogenesis remains unknown, and causal therapy is not available. Implementation of genetics and omics-based approaches in research recognizing the critical importance of calcium phosphate thermodynamics holds promise to unravel MAC molecular pathogenesis and to provide guidance for therapy. The current state of knowledge concerning MAC is reviewed, and future perspectives are outlined.

Citing Articles

A framework of biomarkers for vascular aging: a consensus statement by the Aging Biomarker Consortium.

Zhang L, Guo J, Liu Y, Sun S, Liu B, Yang Q Life Med. 2025; 2(4):lnad033.

PMID: 40040784 PMC: 11879419. DOI: 10.1093/lifemedi/lnad033.


The vasoconstrictor adenosine 5'-tetraphosphate is a danger signal that induces IL-1β.

Bockstiegel J, Engelhardt J, Schuchardt M, Tolle M, Weindl G Mol Med. 2025; 31(1):72.

PMID: 39984847 PMC: 11844157. DOI: 10.1186/s10020-025-01116-6.


Sphingosine kinase 1 inhibition aggravates vascular smooth muscle cell calcification.

Razazian M, Bahiraii S, Jannat I, Tiffner A, Beilhack G, Levkau B Pflugers Arch. 2025; .

PMID: 39899071 DOI: 10.1007/s00424-025-03068-6.


Understanding the Prevalence of Medial Arterial Calcification Among Complex Reconstructive Patients: Insights from a Decade of Experience at a Tertiary Limb Salvage Center.

Rohrich R, Li K, Episalla N, Atkinson K, Lin R, Ferdousian S J Clin Med. 2025; 14(2).

PMID: 39860602 PMC: 11765606. DOI: 10.3390/jcm14020596.


Leveraging artificial intelligence in the fight against aortic calcification.

Zhou J, Wang Y, Liu Y, Ma L, Cui J, Zhang L Chin Med J (Engl). 2025; .

PMID: 39844011 PMC: 11882287. DOI: 10.1097/CM9.0000000000003440.


References
1.
Lachman A, Spray T, KERWIN D, SHUGOLL G, Roberts W . Medial calcinosis of Mönckeberg. A review of the problem and a description of a patient with involvement of peripheral, visceral and coronary arteries. Am J Med. 1977; 63(4):615-22. DOI: 10.1016/0002-9343(77)90207-8. View

2.
Mitchell G . Aortic stiffness, pressure and flow pulsatility, and target organ damage. J Appl Physiol (1985). 2018; 125(6):1871-1880. PMC: 6842890. DOI: 10.1152/japplphysiol.00108.2018. View

3.
Xu J, Bai Y, Jin J, Zhang J, Zhang S, Cui L . Magnesium modulates the expression levels of calcification-associated factors to inhibit calcification in a time-dependent manner. Exp Ther Med. 2015; 9(3):1028-1034. PMC: 4316900. DOI: 10.3892/etm.2015.2215. View

4.
Bon N, Couasnay G, Bourgine A, Sourice S, Beck-Cormier S, Guicheux J . Phosphate (P)-regulated heterodimerization of the high-affinity sodium-dependent P transporters PiT1/Slc20a1 and PiT2/Slc20a2 underlies extracellular P sensing independently of P uptake. J Biol Chem. 2017; 293(6):2102-2114. PMC: 5808770. DOI: 10.1074/jbc.M117.807339. View

5.
Rutsch F, Boyer P, Nitschke Y, Ruf N, Lorenz-Depierieux B, Wittkampf T . Hypophosphatemia, hyperphosphaturia, and bisphosphonate treatment are associated with survival beyond infancy in generalized arterial calcification of infancy. Circ Cardiovasc Genet. 2009; 1(2):133-40. PMC: 2794045. DOI: 10.1161/CIRCGENETICS.108.797704. View